These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8682048

  • 1. Analysis of heart rate variability in a patient with paroxysmal atrial fibrillation.
    van den Berg MP, Haaksma J, Brouwer J, Crijns HJ, Lie KI.
    Eur Heart J; 1995 Dec; 16(12):2011-2. PubMed ID: 8682048
    [No Abstract] [Full Text] [Related]

  • 2. Modifications of heart rate variability preceding the onset of tachyarrhythmias.
    Coumel P.
    Cardiologia; 1990 Jan; 35(1 Suppl):7-12. PubMed ID: 2085829
    [No Abstract] [Full Text] [Related]

  • 3. [Atrial fibrillation and the autonomic nervous system].
    Hohnloser SH, van de Loo A, Klingenheben T.
    Z Kardiol; 1994 Jan; 83 Suppl 5():21-7. PubMed ID: 7846942
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation.
    Kubara I, Ikeda H, Hiraki T, Yoshida T, Ohga M, Imaizumi T.
    J Cardiovasc Electrophysiol; 1999 May; 10(5):670-9. PubMed ID: 10355923
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Management of intermittent atrial fibrillation: drugs to maintain sinus rhythm.
    Olgin JE, Viskin S.
    J Cardiovasc Electrophysiol; 1999 Mar; 10(3):433-41. PubMed ID: 10210511
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Shedding new light on the pathophysiology of conversion of paroxysmal atrial fibrillation into persistent atrial fibrillation.
    Homoud MK, Estes M.
    Am Heart J; 2007 Nov; 154(5):801-4. PubMed ID: 17967581
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardioversion with sotalol in selected patients with vagally and adrenergically mediated paroxysmal atrial fibrillation.
    Yeşil M, Bayata S, Postaci N, Yücel O, Aslan O.
    Angiology; 1999 Sep; 50(9):729-33. PubMed ID: 10496499
    [Abstract] [Full Text] [Related]

  • 16. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G, Blatt A, Kaluski E, Metzkor-Cotter E, Koren M, Litinski I, Simantov R, Moshkovitz Y, Zaidenstein R, Peleg E, Vered Z, Golik A.
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased high-frequency power may not reflect increased vagal tone.
    Stein PK.
    Am J Cardiol; 1999 Feb 01; 83(3):476. PubMed ID: 10072250
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.